These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4479350)

  • 1. 14C-antipyrine as a model compound in the study of drug oxidation and enzyme induction in individual surviving rats.
    Bakke OM; Bending M; Aarbakke J; Davies DS
    Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):91-7. PubMed ID: 4479350
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme induction in sheep: effects of phenobarbital on in vivo and in vitro drug metabolism.
    Shetty SN; Himes JA; Edds GT
    Am J Vet Res; 1972 May; 33(5):935-42. PubMed ID: 4112405
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of drug pretreatment on antipyrine levels in blood and tissues: an example of multiple drug interactions.
    Sotaniemi EA
    Pharmacology; 1973; 10(5):306-16. PubMed ID: 4764537
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding and oxidation of amitriptyline and a series of its oxidized metabolites in liver microsomes from untreated and phenobarbital-treated rats.
    von Bahr C
    Xenobiotica; 1972 May; 2(3):293-306. PubMed ID: 5076574
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species.
    McManus ME; Ilett KF
    Xenobiotica; 1979 Feb; 9(2):107-18. PubMed ID: 433309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent enzyme induction.
    Breckenridge A; Davies DS; Davies L; Orme M
    Br J Pharmacol; 1973 Mar; 47(3):616P-617P. PubMed ID: 4730838
    [No Abstract]   [Full Text] [Related]  

  • 8. [Enhanced drug hydroxylation in man under diphenyl-hydantoin therapy].
    Petruch F; Schüppel RV
    Arzneimittelforschung; 1974 Jul; 24(7):1023-5. PubMed ID: 4211429
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antipyrine breath test in the rat: a pharmacokinetic model.
    Lockwood GF; Chenery RJ; Oldham HG; Standring P; Norman SJ
    Eur J Drug Metab Pharmacokinet; 1988; 13(3):207-14. PubMed ID: 3149242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal effects on antipyrine metabolite kinetics in Aroclor 1254-treated rats.
    Shaw PN; Houston JB
    Toxicol Appl Pharmacol; 1986 Jun; 84(2):232-40. PubMed ID: 3087023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
    Tse FL; Chang T; Jaffe JM
    Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):181-94. PubMed ID: 3963935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of dimethylformamide and dimethylacetamide.
    Barnes JR; Ranta KE
    Toxicol Appl Pharmacol; 1972 Oct; 23(2):271-6. PubMed ID: 5074575
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of phenobarbital steady state levels on antipyrine clearance and distribution in the rat.
    Pei YY; Bialer M; Levy RH
    Biopharm Drug Dispos; 1986; 7(1):11-9. PubMed ID: 3955196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of the antipyrine test for studying microsomal drug oxidation].
    Viktorov AP; Rybak AT
    Farmakol Toksikol; 1990; 53(1):74-7. PubMed ID: 2184052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of hepatic drug oxidation and its relationship to individual differences in rates of oxidation in man.
    Davies DS; Thorgeirsson SS
    Ann N Y Acad Sci; 1971 Jul; 179():411-20. PubMed ID: 5285386
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzyme induction and renal function in man.
    Ohnhaus EE; Martin J; Kinser J; Colombo JP
    Br J Clin Pharmacol; 1977 Feb; 4(1):33-7. PubMed ID: 843422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative drug metabolism and inducibility by phenobarbital in sickle cell anemia.
    Anderson KE; Peterson CM; Alvares AP; Kappas A
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):580-7. PubMed ID: 913026
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of age on antipyrine metabolism by liver microsomes isolated from phenobarbital-treated rats.
    Henderson DJ; van Bezooijen CF
    Mech Ageing Dev; 1989 Sep; 49(3):287-94. PubMed ID: 2811495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High speed liquid chromatography, 14C-radioassay and spectrophotometry for measuring antipyrine plasma half-life in rhesus monkeys (Macaca mulatta).
    Clark CR; Krieger RI; Miller JL
    Pharmacology; 1978; 17(2):98-103. PubMed ID: 98774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.